Short Communication: Medication Adherence: Most Important but Mostly Avoided

Abdul Kader Mohiuddin

doi:doi:10.11648/j.ajnhs.20230401.12

| Peer-Reviewed

Short Communication: Medication Adherence: Most Important but Mostly Avoided

Abdul Kader Mohiuddin

Published in American Journal of Nursing and Health Sciences (Volume 4, Issue 1)

Received: 16 November 2022 Accepted: 9 December 2022 Published: 3 March 2023

Views: Downloads:

Download PDF

Share This Article

Twitter
Linked In
Facebook

Abstract

The indices of patients’ health outcomes have historically included recurrence of symptoms, number of emergency visits, hospitalization and re-admission rates, morbidity, and mortality. Even patients from developed nations have trouble staying on top of their drug compliance. When it comes to improper medicine use, there is an odd parallel between underdeveloped, emerging nations and the so-called developed world in the West. The key factor influencing whether patients stick to their treatment plan is their understanding and perception of the disease. Medication adherence was already a difficult and complex health behavior prior to the COVID-19 pandemic and the disruptions it brought. The promptness of disease diagnosis and management, the cost of treatment, the availability of health insurance, and medication adherence are all factors that providers, who play a significant role in the healthcare system, can affect. Beyond the availability and accessibility of healthcare, the ability of patients to follow doctors' treatment advice greatly contributes to patient outcomes. Unfortunately, there has been a lot of medication non-adherence, which has led to worsened health conditions, higher healthcare costs, and higher healthcare spending. Care providers in clinic and pharmacy settings can set up routines to support adherence to medication and educate and encourage patients about services like distance-accessible technologies and online ordering of medications.

Published in	American Journal of Nursing and Health Sciences (Volume 4, Issue 1)
DOI	10.11648/j.ajnhs.20230401.12
Page(s)	6-11
Creative Commons	This is an Open Access article, distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution and reproduction in any medium or format, provided the original work is properly cited.
Copyright	Copyright © The Author(s), 2023. Published by Science Publishing Group

Keywords

Patient Compliance, Healthcare Denials, Medication Adherence, Elderly Patient Care, Treatment Failure

References

[1]	Grissinger M. (2010). The Five Rights: A Destination Without a Map. Pharmacy and Therapeutics, 35 (10), 542.
[2]	Brown MT, Bussell JK. Medication adherence: WHO cares? Mayo Clin Proc. 2011 Apr; 86 (4): 304-14. doi: 10.4065/mcp.2010.0575.
[3]	Center for Drug Evaluation and Research. (n.d.). Why you need to take your medications as prescribed or instructed. U.S. Food and Drug Administration. Retrieved November 5, 2022, from https://www.fda.gov/drugs/special-features/why-you-need-take-your-medications-prescribed-or-instructed
[4]	Barnett NLMedication adherence: where are we now? A UK perspective European Journal of Hospital Pharmacy: Science and Practice 2014; 21: 181-184. https://doi.org/10.1136/ejhpharm-2013-000373
[5]	Campbell, Denis, and Pamela Duncan. “Record 6.8m People Waiting for Hospital Treatment in England.” The Guardian, 8 Sept. 2022, www.theguardian.com/society/2022/sep/08/waiting-lists-for-routine-hospital-treatment-in-england-break-record.
[6]	Andrews, Luke. “60% of Patients Waiting 18 Wks for Treatment at Worst-performing Trust.” Mail Online, 7 Mar. 2022, www.dailymail.co.uk/news/article-10577387/60-NHS-patients-waited-18-weeks-treatment-worst-performing-hospital-trust.html.
[7]	Mohiuddin, A. K. “Chapter 14. Patient Compliance”. The Role of the Pharmacist in Patient Care: Achieving High Quality, Cost-Effective and Accessible Healthcare Through a Team-Based, Patient-Centered Approach, Universal-Publishers, 2020, pp. 250-270. https://www.universal-publishers.com/book.php?method=ISBN&book=1627343083
[8]	Cutler RL, Torres-Robles A, Wiecek E, Drake B, Van der Linden N, Benrimoj SI, Garcia-Cardenas V. Pharmacist-led medication non-adherence intervention: reducing the economic burden placed on the Australian health care system. Patient Prefer Adherence. 2019; 13: 853-862 https://doi.org/10.2147/PPA.S191482
[9]	Lim, Renly, et al. “The Extent of Medication-Related Hospital Admissions in Australia: A Review from 1988 to 2021.” Drug Safety, vol. 45, no. 3, 28 Jan. 2022, pp. 249–257. https://doi.org/10.1007/s40264-021-01144-1.
[10]	“Medication Nonadherence: Medicine's Weakest Link.” Wolters Kluwer, Health/Experts Insight, 13 Feb. 2020, https://www.wolterskluwer.com/en/expert-insights/medication-nonadherence-medicines-weakest-link.
[11]	Kardas, Przemysław et al. “Reimbursed medication adherence enhancing interventions in 12 european countries: Current state of the art and future challenges.” Frontiers in pharmacology vol. 13 944829. 11 Aug. 2022, doi: 10.3389/fphar.2022.944829.
[12]	van Boven JF, Tsiligianni I, Potočnjak I, Mihajlović J, Dima AL, Nabergoj Makovec U, Ágh T, Kardas P, Ghiciuc CM, Petrova G, Bitterman N, Kamberi F, Culig J, Wettermark B. European Network to Advance Best Practices and Technology on Medication Adherence: Mission Statement. Front Pharmacol. 2021 Oct 11; 12: 748702. doi: 10.3389/fphar.2021.748702.
[13]	Bonsu KO, Young S, Lee T, Nguyen H, Chitsike RS. Adherence to Antithrombotic Therapy for Patients Attending a Multidisciplinary Thrombosis Service in Canada - A Cross-Sectional Survey. Patient Prefer Adherence. 2022 Jul 26; 16: 1771-1780. doi: 10.2147/PPA.S367105.
[14]	Zhang Y, Flory JH, Bao Y. Chronic Medication Nonadherence and Potentially Preventable Healthcare Utilization and Spending Among Medicare Patients. J Gen Intern Med. 2022 Nov; 37 (14): 3645-3652. doi: 10.1007/s11606-021-07334-y.
[15]	Bulik, Beth Snyder. “Nonadherence Costs Pharma $600B-plus in Annual Sales: Study.” Fierce Pharma, 22 Nov. 2016, https://www.fiercepharma.com/marketing/non-adherence-costs-healthcare-system-patient-outcomes-and-pharma-bottom-line.
[16]	Bahta M, Tesfamariam S, Weldemariam DG, Yemane H, Tesfamariam EH, Alem T, Russom M. Dispensing of antibiotics without prescription and associated factors in drug retail outlets of Eritrea: A simulated client method. PLoS One. 2020 Jan 24; 15 (1): e0228013. doi: 10.1371/journal.pone.0228013.
[17]	“Improve Antibiotic Use.” Centers for Disease Control and Prevention, Centers for Disease Control and Prevention, 9 Mar. 2022, https://www.cdc.gov/sixeighteen/hai/index.htm.
[18]	Antimicrobial Resistance Collaborators. Global burden of bacterial antimicrobial resistance in 2019: a systematic analysis. Lancet. 2022 Feb 12; 399 (10325): 629-655. doi: 10.1016/S0140-6736(21)02724-0.
[19]	Rawson TM, Moore LSP, Zhu N, et al. Bacterial and fungal coinfection in individuals with coronavirus: a rapid review to support COVID-19 antimicrobial prescribing. Clin Infect Dis. 2020; 71: 2459-2468.
[20]	Clancy CJ, Nguyen MH. Coronavirus disease 2019, superinfections, and antimicrobial development: what can we expect? Clin Infect Dis. 2020; 71: 2736-2743.
[21]	Daria, Sohel, and Md Rabiul Islam. “Indiscriminate Use of Antibiotics for COVID-19 Treatment in South Asian Countries is a Threat for Future Pandemics Due to Antibiotic Resistance.” Clinical pathology (Thousand Oaks, Ventura County, Calif.) vol. 15 2632010X221099889. 18 May. 2022, doi: 10.1177/2632010X221099889.
[22]	Langford B. J., So M., Raybardhan S., Leung V., Soucy J. R., Westwood D., Daneman N., MacFadden D. R. Antibiotic prescribing in patients with COVID-19: Rapid review and meta-analysis. Clin. Microbiol. Infect. 2021; 27: 520–531. doi: 10.1016/j.cmi.2020.12.018.
[23]	Cong W., Poudel A. N., Alhusein N., Wang H., Yao G., Lambert H. Antimicrobial Use in COVID-19 Patients in the First Phase of the SARS-CoV-2 Pandemic: A Scoping Review. Antibiotics. 2021; 10: 745. doi: 10.3390/antibiotics10060745.
[24]	Kamara, Ibrahim Franklyn et al. “Antibiotic Use in Suspected and Confirmed COVID-19 Patients Admitted to Health Facilities in Sierra Leone in 2020-2021: Practice Does Not Follow Policy.” International journal of environmental research and public health vol. 19, 7 4005. 28 Mar. 2022, doi: 10.3390/ijerph19074005.
[25]	Usman M, Farooq M, Hanna K. Environmental side effects of the injudicious use of antimicrobials in the era of COVID-19. Sci Total Environ. 2020; 745: 141053. doi: 10.1016/j.scitotenv.2020.141053.
[26]	Kasciuškevičiūtė S, Gumbrevičius G, Vendzelytė A, Ščiupokas A, Petrikonis K, Kaduševičius E. Impact of the World Health Organization Pain Treatment Guidelines and the European Medicines Agency Safety Recommendations on Nonsteroidal Anti-Inflammatory Drug Use in Lithuania: An Observational Study. Medicina (Kaunas). 2018 May 11; 54 (2): 30. doi: 10.3390/medicina54020030.
[27]	Davis, Abigail, and John Robson. “The Dangers of NSAIDs: Look Both Ways.” British Journal of General Practice, vol. 66, no. 645, 2016, pp. 172–173. https://doi.org/10.3399/bjgp16x684433.
[28]	Lucas GNC, Leitão ACC, Alencar RL, Xavier RMF, Daher EF, Silva Junior GBD. Pathophysiological aspects of nephropathy caused by non-steroidal anti-inflammatory drugs. J Bras Nefrol. 2019 Jan-Mar; 41 (1): 124-130. doi: 10.1590/2175-8239-JBN-2018-0107.
[29]	Mohiuddin, Abdul Kader. “Taking Medicine in the Right Way: Most Important but Most Neglected.” Cases, vol. 1, no. 1, 13 Nov. 2022, pp. 1–3., https://doi.org/https://doi.org/10.35702/cases.10003. https://www.jcases.org/articles/taking-medicine-in-the-right-way-most-important-but-most-neglected.pdf
[30]	Jahrami H, BaHammam AS, Bragazzi NL, Saif Z, Faris M, Vitiello MV. Sleep problems during the COVID-19 pandemic by population: a systematic review and meta-analysis. J Clin Sleep Med. 2021 Feb 1; 17 (2): 299-313. doi: 10.5664/jcsm.8930.
[31]	Ostuzzi G, Papola D, Gastaldon C, Schoretsanitis G, Bertolini F, Amaddeo F, Cuomo A, Emsley R, Fagiolini A, Imperadore G, Kishimoto T, Michencigh G, Nosé M, Purgato M, Dursun S, Stubbs B, Taylor D, Thornicroft G, Ward PB, Hiemke C, Correll CU, Barbui C. Safety of psychotropic medications in people with COVID-19: evidence review and practical recommendations. BMC Med. 2020 Jul 15; 18 (1): 215. doi: 10.1186/s12916-020-01685-9.
[32]	Sarangi, Ashish et al. “Benzodiazepine Misuse: An Epidemic Within a Pandemic.” Cureus vol. 13, 6 e15816. 21 Jun. 2021, doi: 10.7759/cureus.15816.
[33]	Bhadelia A, De Lima L, Arreola-Ornelas H, Kwete XJ, Rodriguez NM, Knaul FM. Solving the Global Crisis in Access to Pain Relief: Lessons From Country Actions. Am J Public Health. 2019 Jan; 109 (1): 58-60. doi: 10.2105/AJPH.2018.304769.
[34]	Lopez, German. “Marijuana Majority/ Americans Support Marijuana Legalization, but Many of Their Political Leaders Do Not.” The New York Times, 23 Nov. 2022, https://www.nytimes.com/2022/11/23/briefing/legal-weed-marijuana.html. Accessed 30 Nov. 2022.
[35]	Oltermann, Philip. “Germany Announces Plan to Legalise Cannabis for Recreational Use.” The Guardian, 26 Oct. 2022, https://www.theguardian.com/world/2022/oct/26/germany-to-legalise-cannabis-for-recreational-use. Accessed 30 Nov. 2022.
[36]	Shahid, Rabia et al. “Impact of low health literacy on patients' health outcomes: a multicenter cohort study.” BMC health services research vol. 22, 1 1148. 12 Sep. 2022, doi: 10.1186/s12913-022-08527-9.
[37]	Alam, Md Moddassir et al. “Public Attitude Towards COVID-19 Vaccination: Validation of COVID-Vaccination Attitude Scale (C-VAS).” Journal of multidisciplinary healthcare vol. 15 941-954. 29 Apr. 2022, doi: 10.2147/JMDH.S353594.
[38]	Danabal, K. G. M., Magesh, S. S., Saravanan, S. et al. Attitude towards COVID-19 vaccines and vaccine hesitancy in urban and rural communities in Tamil Nadu, India – a community based survey. BMC Health Serv Res 21, 994 (2021). https://doi.org/10.1186/s12913-021-07037-4
[39]	Leelavathy, Manju et al. “Attitude towards COVID-19 vaccination among the public in Kerala: A cross sectional study.” Journal of family medicine and primary care vol. 10, 11 (2021): 4147-4152. doi: 10.4103/jfmpc.jfmpc_583_21.
[40]	Paul, Elise et al. “Attitudes towards vaccines and intention to vaccinate against COVID-19: Implications for public health communications.” The Lancet regional health. Europe vol. 1 (2021): 100012. doi: 10.1016/j.lanepe.2020.100012.
[41]	Chauke GD, Nakwafila O, Chibi B, Sartorius B, Mashamba-Thompson T. Factors influencing poor medication adherence amongst patients with chronic disease in low-and-middle-income countries: A systematic scoping review. Heliyon. 2022 Jun 15; 8 (6): e09716. doi: 10.1016/j.heliyon.2022.e09716.
[42]	Chong E, Wang H, King-Shier KM, Quan H, Rabi DM, Khan NA. Prescribing patterns and adherence to medication among South-Asian, Chinese and white people with Type 2 diabetes mellitus: a population-based cohort study. Diabet Med. 2014. August 11 10.1111/dme.12559.
[43]	Sohal T, Sohal P, King-Shier KM, Khan NA. Barriers and Facilitators for Type-2 Diabetes Management in South Asians: A Systematic Review. PLoS One. 2015 Sep 18; 10 (9): e0136202. doi: 10.1371/journal.pone.0136202.
[44]	Alsairafi ZK, Taylor KM, Smith FJ, Alattar AT. Patients' management of type 2 diabetes in Middle Eastern countries: review of studies. Patient Prefer Adherence. 2016 Jun 10; 10: 1051-62. doi: 10.2147/PPA.S104335.
[45]	Almigbal, Turky H et al. “Association of health literacy and self-management practices and psychological factor among patients with type 2 diabetes mellitus in Saudi Arabia.” Saudi medical journal vol. 40, 11 (2019): 1158-1166. doi: 10.15537/smj.2019.11.24585.
[46]	Nair, Satish Chandrasekhar et al. “Health literacy in a high income Arab country: A nation-wide cross-sectional survey study.” PloS one vol. 17, 10 e0275579. 5 Oct. 2022, doi: 10.1371/journal.pone.0275579.
[47]	Hashim, Saman Agad et al. “Association of Health Literacy and Nutritional Status Assessment with Glycemic Control in Adults with Type 2 Diabetes Mellitus.” Nutrients vol. 12, 10 3152. 15 Oct. 2020, doi: 10.3390/nu12103152.
[48]	Hussein, Shaimaa H et al. “Association of health literacy and other risk factors with glycemic control among patients with type 2 diabetes in Kuwait: A cross-sectional study.” Primary care diabetes vol. 15, 3 (2021): 571-577. doi: 10.1016/j.pcd.2021.01.011.
[49]	Khatiwada, Bhushan, et al. “Prevalence of and Factors Associated with Health Literacy among People with Noncommunicable Diseases (Ncds) in South Asian Countries: A Systematic Review.” Clinical Epidemiology and Global Health, vol. 18, 3 Nov. 2022, p. 101174., https://doi.org/10.1016/j.cegh.2022.101174.
[50]	Rajah R., Hassali M. A. A., Murugiah M. K. A systematic review of the prevalence of limited health literacy in Southeast Asian countries. Public Health. 2019; 167: 8–15. doi: 10.1016/j.puhe.2018.09.028.
[51]	Saleh, Ariyanti, et al. “The Relationships among Self-Efficacy, Health Literacy, Self-Care and Glycemic Control in Older People with Type 2 Diabetes Mellitus.” Working with Older People, vol. 25, no. 2, 4 May 2021, pp. 164–169. https://doi.org/10.1108/wwop-08-2020-0044.
[52]	Choudhry NK, Kronish IM, Vongpatanasin W, Ferdinand KC, Pavlik VN, Egan BM, Schoenthaler A, Houston Miller N, Hyman DJ; American Heart Association Council on Hypertension; Council on Cardiovascular and Stroke Nursing; and Council on Clinical Cardiology. Medication Adherence and Blood Pressure Control: A Scientific Statement From the American Heart Association. Hypertension. 2022 Jan; 79 (1): e1-e14. doi: 10.1161/HYP.0000000000000203.
[53]	Elnaem, Mohamed Hassan et al. “Disparities in Prevalence and Barriers to Hypertension Control: A Systematic Review.” International journal of environmental research and public health vol. 19, 21 14571. 6 Nov. 2022, doi: 10.3390/ijerph192114571.
[54]	Keasley, James et al. “A systematic review of the burden of hypertension, access to services and patient views of hypertension in humanitarian crisis settings.” BMJ global health vol. 5, 11 (2020): e002440. doi: 10.1136/bmjgh-2020-002440.
[55]	Alawneh, Issa S et al. “The Prevalence of Uncontrolled Hypertension among Patients Taking Antihypertensive Medications and the Associated Risk Factors in North Palestine: A Cross-Sectional Study.” Advances in medicine vol. 2022 5319756. 25 Aug. 2022, doi: 10.1155/2022/5319756.
[56]	Rahman, Ayesha, et al. “Non-Communicable Diseases Risk Factors among the Forcefully Displaced Rohingya Population in Bangladesh.” PLOS Global Public Health, vol. 2, no. 9, 27 Sept. 2022, https://doi.org/10.1371/journal.pgph.0000930.
[57]	Lossius, M. I., Alfstad, K. Å., Aaberg, K. M., & Nakken, K. O. (2017). Seponering av Antiepileptika Ved anfallsfrihet – når og hvordan? Tidsskrift for Den Norske Legeforening, 137 (6), 451–454. https://doi.org/10.4045/tidsskr.16.0957
[58]	Yang, D. Zhonghua shen jing jing shen ke za zhi = Chinese journal of neurology and psychiatry vol. 25, 4 (1992): 215-8, 253.
[59]	Banerjee S, Varma RP. Factors affecting non-adherence among patients diagnosed with unipolar depression in a psychiatric department of a tertiary hospital in Kolkata, India. Depress Res Treat. 2013; 2013: 809542.
[60]	Graeupner D, Coman A. The dark side of meaning-making: How social exclusion leads to superstitious thinking. Journal of Experimental Social Psychology. 2017; 69: 218–22.
[61]	Puckree T, Mkhize M, Mgobhozi Z, Lin J. African traditional healers: What health care professionals need to know. Int J Rehabil Res. 2002; 25: 247–51.
[62]	Taher, Mohammad et al. “Superstition in health beliefs: Concept exploration and development.” Journal of family medicine and primary care vol. 9, 3 1325-1330. 26 Mar. 2020, doi: 10.4103/jfmpc.jfmpc_871_19.
[63]	Grim, Brian J, and Melissa E Grim. “Belief, Behavior, and Belonging: How Faith is Indispensable in Preventing and Recovering from Substance Abuse.” Journal of religion and health vol. 58, 5 (2019): 1713-1750. doi: 10.1007/s10943-019-00876-w.
[64]	Mirahmadizadeh, Alireza et al. “Factors Affecting Insulin Compliance in Patients with Type 2 Diabetes in South Iran, 2017: We Are Faced with Insulin Phobia.” Iranian journal of medical sciences vol. 44, 3 (2019): 204-213.
[65]	Félix IB, Henriques A. Medication adherence and related determinants in older people with multimorbidity: a cross sectional study. Nurs Forum. 2021; 56: 834–843. doi: 10.1111/nuf.12619.
[66]	Chippa, Venu, and Kamalika Roy. “Geriatric Cognitive Decline and Polypharmacy.” National Library of Medicine, StatPearls Publishing, Jan. 2022, https://www.ncbi.nlm.nih.gov/books/NBK574575/.
[67]	Varghese D, Ishida C, Haseer Koya H. Polypharmacy. National Library of Medicine, StatPearls Publishing, Jan. 2022, https://www.ncbi.nlm.nih.gov/books/NBK532953/.
[68]	Santer, Miriam et al. “Treatment non-adherence in pediatric long-term medical conditions: systematic review and synthesis of qualitative studies of caregivers' views.” BMC pediatrics vol. 14 63. 4 Mar. 2014, doi: 10.1186/1471-2431-14-63.
[69]	Al-Hassany, Linda et al. “Assessing methods of measuring medication adherence in chronically ill children-a narrative review.” Patient preference and adherence vol. 13 1175-1189. 22 Jul. 2019, doi: 10.2147/PPA.S200058.
[70]	Wu, Y Y et al. Zhonghua er ke za zhi = Chinese journal of pediatrics vol. 60, 11 (2022): 1191-1195. doi: 10.3760/cma.j.cn112140-20220110-00036.
[71]	Jin J, Sklar GE, Min Sen Oh V, Chuen Li S. Factors affecting therapeutic compliance: A review from the patient's perspective. Ther Clin Risk Manag. 2008 Feb; 4 (1): 269-86. doi: 10.2147/tcrm.s1458.
[72]	Wilder, Marcee E et al. “The Impact of Social Determinants of Health on Medication Adherence: a Systematic Review and Meta-analysis.” Journal of general internal medicine vol. 36, 5 (2021): 1359-1370. doi: 10.1007/s11606-020-06447-0.
[73]	Kardas, Przemyslaw et al. “Determinants of patient adherence: a review of systematic reviews.” Frontiers in pharmacology vol. 4 91. 25 Jul. 2013, doi: 10.3389/fphar.2013.00091.

Cite This Article

Plain Text BibTeX RIS

APA Style

Abdul Kader Mohiuddin. (2023). Short Communication: Medication Adherence: Most Important but Mostly Avoided. American Journal of Nursing and Health Sciences, 4(1), 6-11. https://doi.org/10.11648/j.ajnhs.20230401.12

Copy | Download

ACS Style

Abdul Kader Mohiuddin. Short Communication: Medication Adherence: Most Important but Mostly Avoided. Am. J. Nurs. Health Sci. 2023, 4(1), 6-11. doi: 10.11648/j.ajnhs.20230401.12

Copy | Download

AMA Style

Abdul Kader Mohiuddin. Short Communication: Medication Adherence: Most Important but Mostly Avoided. Am J Nurs Health Sci. 2023;4(1):6-11. doi: 10.11648/j.ajnhs.20230401.12

Copy | Download

@article{10.11648/j.ajnhs.20230401.12,
  author = {Abdul Kader Mohiuddin},
  title = {Short Communication: Medication Adherence: Most Important but Mostly Avoided},
  journal = {American Journal of Nursing and Health Sciences},
  volume = {4},
  number = {1},
  pages = {6-11},
  doi = {10.11648/j.ajnhs.20230401.12},
  url = {https://doi.org/10.11648/j.ajnhs.20230401.12},
  eprint = {https://article.sciencepublishinggroup.com/pdf/10.11648.j.ajnhs.20230401.12},
  abstract = {The indices of patients’ health outcomes have historically included recurrence of symptoms, number of emergency visits, hospitalization and re-admission rates, morbidity, and mortality. Even patients from developed nations have trouble staying on top of their drug compliance. When it comes to improper medicine use, there is an odd parallel between underdeveloped, emerging nations and the so-called developed world in the West. The key factor influencing whether patients stick to their treatment plan is their understanding and perception of the disease. Medication adherence was already a difficult and complex health behavior prior to the COVID-19 pandemic and the disruptions it brought. The promptness of disease diagnosis and management, the cost of treatment, the availability of health insurance, and medication adherence are all factors that providers, who play a significant role in the healthcare system, can affect. Beyond the availability and accessibility of healthcare, the ability of patients to follow doctors' treatment advice greatly contributes to patient outcomes. Unfortunately, there has been a lot of medication non-adherence, which has led to worsened health conditions, higher healthcare costs, and higher healthcare spending. Care providers in clinic and pharmacy settings can set up routines to support adherence to medication and educate and encourage patients about services like distance-accessible technologies and online ordering of medications.},
 year = {2023}
}

Copy | Download

TY  - JOUR
T1  - Short Communication: Medication Adherence: Most Important but Mostly Avoided
AU  - Abdul Kader Mohiuddin
Y1  - 2023/03/03
PY  - 2023
N1  - https://doi.org/10.11648/j.ajnhs.20230401.12
DO  - 10.11648/j.ajnhs.20230401.12
T2  - American Journal of Nursing and Health Sciences
JF  - American Journal of Nursing and Health Sciences
JO  - American Journal of Nursing and Health Sciences
SP  - 6
EP  - 11
PB  - Science Publishing Group
SN  - 2994-7227
UR  - https://doi.org/10.11648/j.ajnhs.20230401.12
AB  - The indices of patients’ health outcomes have historically included recurrence of symptoms, number of emergency visits, hospitalization and re-admission rates, morbidity, and mortality. Even patients from developed nations have trouble staying on top of their drug compliance. When it comes to improper medicine use, there is an odd parallel between underdeveloped, emerging nations and the so-called developed world in the West. The key factor influencing whether patients stick to their treatment plan is their understanding and perception of the disease. Medication adherence was already a difficult and complex health behavior prior to the COVID-19 pandemic and the disruptions it brought. The promptness of disease diagnosis and management, the cost of treatment, the availability of health insurance, and medication adherence are all factors that providers, who play a significant role in the healthcare system, can affect. Beyond the availability and accessibility of healthcare, the ability of patients to follow doctors' treatment advice greatly contributes to patient outcomes. Unfortunately, there has been a lot of medication non-adherence, which has led to worsened health conditions, higher healthcare costs, and higher healthcare spending. Care providers in clinic and pharmacy settings can set up routines to support adherence to medication and educate and encourage patients about services like distance-accessible technologies and online ordering of medications.
VL  - 4
IS  - 1
ER  -

Copy | Download

Author Information

Abdul Kader Mohiuddin

Faculty of Pharmacy, Dhaka University, Dhaka, Bangladesh

Download PDF

Sections

Plain Text BibTeX RIS

APA Style

Abdul Kader Mohiuddin. (2023). Short Communication: Medication Adherence: Most Important but Mostly Avoided. American Journal of Nursing and Health Sciences, 4(1), 6-11. https://doi.org/10.11648/j.ajnhs.20230401.12

Copy | Download

ACS Style

Abdul Kader Mohiuddin. Short Communication: Medication Adherence: Most Important but Mostly Avoided. Am. J. Nurs. Health Sci. 2023, 4(1), 6-11. doi: 10.11648/j.ajnhs.20230401.12

Copy | Download

AMA Style

Abdul Kader Mohiuddin. Short Communication: Medication Adherence: Most Important but Mostly Avoided. Am J Nurs Health Sci. 2023;4(1):6-11. doi: 10.11648/j.ajnhs.20230401.12

Copy | Download

@article{10.11648/j.ajnhs.20230401.12,
  author = {Abdul Kader Mohiuddin},
  title = {Short Communication: Medication Adherence: Most Important but Mostly Avoided},
  journal = {American Journal of Nursing and Health Sciences},
  volume = {4},
  number = {1},
  pages = {6-11},
  doi = {10.11648/j.ajnhs.20230401.12},
  url = {https://doi.org/10.11648/j.ajnhs.20230401.12},
  eprint = {https://article.sciencepublishinggroup.com/pdf/10.11648.j.ajnhs.20230401.12},
  abstract = {The indices of patients’ health outcomes have historically included recurrence of symptoms, number of emergency visits, hospitalization and re-admission rates, morbidity, and mortality. Even patients from developed nations have trouble staying on top of their drug compliance. When it comes to improper medicine use, there is an odd parallel between underdeveloped, emerging nations and the so-called developed world in the West. The key factor influencing whether patients stick to their treatment plan is their understanding and perception of the disease. Medication adherence was already a difficult and complex health behavior prior to the COVID-19 pandemic and the disruptions it brought. The promptness of disease diagnosis and management, the cost of treatment, the availability of health insurance, and medication adherence are all factors that providers, who play a significant role in the healthcare system, can affect. Beyond the availability and accessibility of healthcare, the ability of patients to follow doctors' treatment advice greatly contributes to patient outcomes. Unfortunately, there has been a lot of medication non-adherence, which has led to worsened health conditions, higher healthcare costs, and higher healthcare spending. Care providers in clinic and pharmacy settings can set up routines to support adherence to medication and educate and encourage patients about services like distance-accessible technologies and online ordering of medications.},
 year = {2023}
}

Copy | Download

TY  - JOUR
T1  - Short Communication: Medication Adherence: Most Important but Mostly Avoided
AU  - Abdul Kader Mohiuddin
Y1  - 2023/03/03
PY  - 2023
N1  - https://doi.org/10.11648/j.ajnhs.20230401.12
DO  - 10.11648/j.ajnhs.20230401.12
T2  - American Journal of Nursing and Health Sciences
JF  - American Journal of Nursing and Health Sciences
JO  - American Journal of Nursing and Health Sciences
SP  - 6
EP  - 11
PB  - Science Publishing Group
SN  - 2994-7227
UR  - https://doi.org/10.11648/j.ajnhs.20230401.12
AB  - The indices of patients’ health outcomes have historically included recurrence of symptoms, number of emergency visits, hospitalization and re-admission rates, morbidity, and mortality. Even patients from developed nations have trouble staying on top of their drug compliance. When it comes to improper medicine use, there is an odd parallel between underdeveloped, emerging nations and the so-called developed world in the West. The key factor influencing whether patients stick to their treatment plan is their understanding and perception of the disease. Medication adherence was already a difficult and complex health behavior prior to the COVID-19 pandemic and the disruptions it brought. The promptness of disease diagnosis and management, the cost of treatment, the availability of health insurance, and medication adherence are all factors that providers, who play a significant role in the healthcare system, can affect. Beyond the availability and accessibility of healthcare, the ability of patients to follow doctors' treatment advice greatly contributes to patient outcomes. Unfortunately, there has been a lot of medication non-adherence, which has led to worsened health conditions, higher healthcare costs, and higher healthcare spending. Care providers in clinic and pharmacy settings can set up routines to support adherence to medication and educate and encourage patients about services like distance-accessible technologies and online ordering of medications.
VL  - 4
IS  - 1
ER  -

Copy | Download